These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 23550448

  • 1. [New surgical approaches to localized and advanced gastrointestinal stromal tumors (GIST)].
    Bonvalot S, Honoré C.
    Bull Acad Natl Med; 2012; 196(4-5):855-60; discussion 860. PubMed ID: 23550448
    [Abstract] [Full Text] [Related]

  • 2. [An update of the surgical indications for gastrointestinal stromal tumors].
    Bonvalot S.
    J Chir (Paris); 2008; 145 Suppl 3():6S8-11. PubMed ID: 19060842
    [Abstract] [Full Text] [Related]

  • 3. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [Abstract] [Full Text] [Related]

  • 4. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH.
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [Abstract] [Full Text] [Related]

  • 5. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 6. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.
    Eisenberg BL, Judson I.
    Ann Surg Oncol; 2004 May; 11(5):465-75. PubMed ID: 15123459
    [Abstract] [Full Text] [Related]

  • 7. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P, Nowecki Z, Nyckowski P, Dziewirski W, Grzesiakowska U, Nasierowska-Guttmejer A, Krawczyk M, Ruka W.
    J Surg Oncol; 2006 Mar 15; 93(4):304-11. PubMed ID: 16496358
    [Abstract] [Full Text] [Related]

  • 8. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.
    An HJ, Ryu MH, Ryoo BY, Sohn BS, Kim KH, Oh ST, Yu CS, Yook JH, Kim BS, Kang YK.
    Ann Surg Oncol; 2013 Dec 15; 20(13):4212-8. PubMed ID: 24052319
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M, Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A.
    Eur J Surg Oncol; 2014 Apr 15; 40(4):412-9. PubMed ID: 24491288
    [Abstract] [Full Text] [Related]

  • 10. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
    López RL, del Muro XG.
    Anticancer Drugs; 2012 Jun 15; 23 Suppl():S3-6. PubMed ID: 22739667
    [Abstract] [Full Text] [Related]

  • 11. [GIST: our experience].
    Rossi MT, Fasano G, Morlino A, Scutari F.
    G Chir; 2009 Jun 15; 30(1-2):41-5. PubMed ID: 19272232
    [Abstract] [Full Text] [Related]

  • 12. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
    Park SJ, Ryu MH, Ryoo BY, Park YS, Sohn BS, Kim HJ, Kim CW, Kim KH, Yu CS, Yook JH, Kim BS, Kang YK.
    Ann Surg Oncol; 2014 Dec 15; 21(13):4211-7. PubMed ID: 24980089
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, Hohenberger P.
    Ann Surg Oncol; 2013 Feb 15; 20(2):586-92. PubMed ID: 22965573
    [Abstract] [Full Text] [Related]

  • 14. [Curative resection for bulky gastrointestinal stromal tumor with conversion therapy by imatinib].
    Nishimura T, Sakata K, Maeda Y, Nagashima Y, Okada T, Nakamura M, Setoguchi M.
    Gan To Kagaku Ryoho; 2011 Nov 15; 38(12):2202-4. PubMed ID: 22202330
    [Abstract] [Full Text] [Related]

  • 15. Resection of focally progressive gastrointestinal stromal tumours resistant to imatinib therapy.
    Tse GH, Wong EH, O'Dwyer PJ.
    Surgeon; 2012 Dec 15; 10(6):309-13. PubMed ID: 22123434
    [Abstract] [Full Text] [Related]

  • 16. New fronts in the adjuvant treatment of GIST.
    Reichardt P, Joensuu H, Blay JY.
    Cancer Chemother Pharmacol; 2013 Oct 15; 72(4):715-23. PubMed ID: 23934322
    [Abstract] [Full Text] [Related]

  • 17. [New prospective on adjuvant treatment for gastrointestinal stromal tumors].
    Pan ZZ, Wu XJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar 15; 16(3):212-5. PubMed ID: 23536337
    [Abstract] [Full Text] [Related]

  • 18. Surgery for gastrointestinal stromal tumour in the post-imatinib era.
    Neuhaus SJ, Clark MA, Hayes AJ, Thomas JM, Judson I.
    ANZ J Surg; 2005 Mar 15; 75(3):165-72. PubMed ID: 15777399
    [Abstract] [Full Text] [Related]

  • 19. [Treatment progress of gastrointestinal stromal tumor].
    Ji X, Ji JF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar 15; 16(3):292-6. PubMed ID: 23536354
    [Abstract] [Full Text] [Related]

  • 20. Gastrointestinal stromal tumors.
    Taneva I, Dimitrova V.
    Khirurgiia (Sofiia); 2011 Mar 15; (1):39-47. PubMed ID: 23847801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.